SII CEO Adar Poonawalla takes shot of COVISHIELD vaccine, says 'to endorse its safety'

As India launched its largest vaccination drive, Adar Poonawalla, CEO of Serum Institute of India, took a jab of COVISHIELD vaccine and shared a video. Hailing the efforts of health care workers and wishing the country as well as Prime Minister Narendra Modi a great success, Poonawalla said that he is taking the vaccine shot to "endorse its safety and efficacy." Questions have been raised on the safety of COVISHIELD as the DCGI gave approval for its emergency use during Phase 3 trials.

READ | Centre officially places order with SII for 'COVISHIELD'; cost fixed at Rs 200 per dose

READ | SII's Adar Poonawala Shares Details Of COVID Vaccine: 'First 100m Doses To Cost Rs 200'

Largest vaccination drive 

Prime Minister Narendra Modi on Saturday launched India's COVID-19 vaccination drive and asserted that the made-in-India vaccines being rolled out will ensure a "decisive victory" for the country over the coronavirus pandemic. Addressing the nation ahead of the launch, PM Modi reminded people that two doses of vaccine are very important and asked them to maintain wearing masks and social distancing even after receiving the jabs. "'Dawai bhi, kadai bhi," he said. 

During his speech, PM Modi turned emotional as he spoke of the disruption the pandemic caused to people's lives, isolating victims of the coronavirus and denying the dead traditional last rites. In a choked voice, the prime minister also referred to sacrifices made by healthcare and frontline workers, hundreds of whom lost their lives to the viral infection. He also urged the country to show patience during the vaccination drive as it had shown till now in fighting the pandemic.

"Normally, it takes years to make a vaccine but in such a short span of time, not one, but two 'Made in India' vaccines are ready.  India getting two vaccines in such a short time is a testimony to the talent and skills of the nation's scientists", the prime minister said. "Our vaccination programme is driven by humanitarian concerns, those exposed to maximum risk will get priority," he added.

PM Modi also assured that scientists and experts have given permission for emergency use of the made-in-India vaccines only after being absolutely sure of their safety and the people should be aware of any propaganda and rumours. According to the government, the shots will be offered first to an estimated one crore healthcare workers, and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities. Cost of vaccination of healthcare and frontline workers will be borne by the central government. 

The development comes after the Drugs Controller General of India (DCGI) had earlier this month approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.

READ | India's First COVID-19 Vaccine Recipient Is Manish Kumar, Sanitation Worker In New Delhi

READ | In Emotion-laden Speech, PM Modi Flags Off India's Historic COVID-19 Vaccination drive